These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 29163514)

  • 1. An Unexpected Major Role for Proteasome-Catalyzed Peptide Splicing in Generation of T Cell Epitopes: Is There Relevance for Vaccine Development?
    Platteel ACM; Liepe J; van Eden W; Mishto M; Sijts AJAM
    Front Immunol; 2017; 8():1441. PubMed ID: 29163514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-level Strategy for Identifying Proteasome-Catalyzed Spliced Epitopes Targeted by CD8
    Platteel ACM; Liepe J; Textoris-Taube K; Keller C; Henklein P; Schalkwijk HH; Cardoso R; Kloetzel PM; Mishto M; Sijts AJAM
    Cell Rep; 2017 Aug; 20(5):1242-1253. PubMed ID: 28768206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8(+) T cells of Listeria monocytogenes-infected mice recognize both linear and spliced proteasome products.
    Platteel AC; Mishto M; Textoris-Taube K; Keller C; Liepe J; Busch DH; Kloetzel PM; Sijts AJ
    Eur J Immunol; 2016 May; 46(5):1109-18. PubMed ID: 26909514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A large fraction of HLA class I ligands are proteasome-generated spliced peptides.
    Liepe J; Marino F; Sidney J; Jeko A; Bunting DE; Sette A; Kloetzel PM; Stumpf MP; Heck AJ; Mishto M
    Science; 2016 Oct; 354(6310):354-358. PubMed ID: 27846572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies to enhance immunogenicity of cDNA vaccine encoded antigens by modulation of antigen processing.
    Platteel ACM; Marit de Groot A; Keller C; Andersen P; Ovaa H; Kloetzel PM; Mishto M; Sijts AJAM
    Vaccine; 2016 Sep; 34(42):5132-5140. PubMed ID: 27593157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteasomes generate spliced epitopes by two different mechanisms and as efficiently as non-spliced epitopes.
    Ebstein F; Textoris-Taube K; Keller C; Golnik R; Vigneron N; Van den Eynde BJ; Schuler-Thurner B; Schadendorf D; Lorenz FK; Uckert W; Urban S; Lehmann A; Albrecht-Koepke N; Janek K; Henklein P; Niewienda A; Kloetzel PM; Mishto M
    Sci Rep; 2016 Apr; 6():24032. PubMed ID: 27049119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidation of the Signatures of Proteasome-Catalyzed Peptide Splicing.
    Paes W; Leonov G; Partridge T; Nicastri A; Ternette N; Borrow P
    Front Immunol; 2020; 11():563800. PubMed ID: 33072102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. InvitroSPI and a large database of proteasome-generated spliced and non-spliced peptides.
    Roetschke HP; Rodriguez-Hernandez G; Cormican JA; Yang X; Lynham S; Mishto M; Liepe J
    Sci Data; 2023 Jan; 10(1):18. PubMed ID: 36627305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An in vitro-transcribed-mRNA polyepitope construct encoding 32 distinct HLA class I-restricted epitopes from CMV, EBV, and Influenza for use as a functional control in human immune monitoring studies.
    Nielsen JS; Wick DA; Tran E; Nelson BH; Webb JR
    J Immunol Methods; 2010 Aug; 360(1-2):149-56. PubMed ID: 20637775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress toward an artificial vaccine for HIV: identification of helper and cytotoxic T-cell epitopes and methods of immunization.
    Berzofsky JA
    Biotechnol Ther; 1991; 2(1-2):123-35. PubMed ID: 1726961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An unexplored angle: T cell antigen discoveries reveal a marginal contribution of proteasome splicing to the immunogenic MHC class I antigen pool.
    Verkerk T; Koomen SJI; Fuchs KJ; Griffioen M; Spaapen RM
    Proc Natl Acad Sci U S A; 2022 Jul; 119(29):e2119736119. PubMed ID: 35858315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA class I epitope discovery in type 1 diabetes.
    van Endert P; Hassainya Y; Lindo V; Bach JM; Blancou P; Lemonnier F; Mallone R
    Ann N Y Acad Sci; 2006 Oct; 1079():190-7. PubMed ID: 17130554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficiency and mechanism of antigen-specific CD8+ T-cell activation using synthetic long peptides.
    Zandvliet ML; Kester MG; van Liempt E; de Ru AH; van Veelen PA; Griffioen M; Guchelaar HJ; Falkenburg JH; Meij P
    J Immunother; 2012; 35(2):142-53. PubMed ID: 22306902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical Modification of Influenza CD8+ T-Cell Epitopes Enhances Their Immunogenicity Regardless of Immunodominance.
    Rosendahl Huber SK; Luimstra JJ; van Beek J; Hoppes R; Jacobi RH; Hendriks M; Kapteijn K; Ouwerkerk C; Rodenko B; Ovaa H; de Jonge J
    PLoS One; 2016; 11(6):e0156462. PubMed ID: 27333291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunodominant CD8 T cell response to the human cytomegalovirus tegument phosphoprotein pp65(495-503) epitope critically depends on CD4 T cell help in vaccinated HLA-A*0201 transgenic mice.
    Reiser M; Wieland A; Plachter B; Mertens T; Greiner J; Schirmbeck R
    J Immunol; 2011 Sep; 187(5):2172-80. PubMed ID: 21810614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-chain HLA-A2 MHC trimers that incorporate an immundominant peptide elicit protective T cell immunity against lethal West Nile virus infection.
    Kim S; Li L; McMurtrey CP; Hildebrand WH; Weidanz JA; Gillanders WE; Diamond MS; Hansen TH
    J Immunol; 2010 Apr; 184(8):4423-30. PubMed ID: 20212098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCR-ABL fusion regions as a source of multiple leukemia-specific CD8+ T-cell epitopes.
    Kessler JH; Bres-Vloemans SA; van Veelen PA; de Ru A; Huijbers IJ; Camps M; Mulder A; Offringa R; Drijfhout JW; Leeksma OC; Ossendorp F; Melief CJ
    Leukemia; 2006 Oct; 20(10):1738-50. PubMed ID: 16932347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
    Abrams SI; Khleif SN; Bergmann-Leitner ES; Kantor JA; Chung Y; Hamilton JM; Schlom J
    Cell Immunol; 1997 Dec; 182(2):137-51. PubMed ID: 9514698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression mapping using a retroviral vector for CD8+ T cell epitopes: definition of a Mycobacterium tuberculosis peptide presented by H2-Dd.
    Aoshi T; Suzuki M; Uchijima M; Nagata T; Koide Y
    J Immunol Methods; 2005 Mar; 298(1-2):21-34. PubMed ID: 15847794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.